A detailed history of First Turn Management, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, First Turn Management, LLC holds 684,230 shares of ADMA stock, worth $10.8 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares
684,230
Previous 664,985 2.89%
Holding current value
$10.8 Million
Previous $13.3 Billion 11.72%
% of portfolio
2.1%
Previous 2.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$15.62 - $22.62 $300,606 - $435,321
19,245 Added 2.89%
684,230 $11.7 Billion
Q3 2024

Nov 07, 2024

BUY
$11.21 - $20.03 $7.45 Million - $13.3 Million
664,985 New
664,985 $13.3 Billion

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.11B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track First Turn Management, LLC Portfolio

Follow First Turn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Turn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Turn Management, LLC with notifications on news.